Hematopoietic and Nature Killer Cell Development from Human Pluripotent Stem Cells
Authors:
- 22 May 2013
- book chapter
- Published by Springer Nature
- Vol. 1029, 33-41
Abstract
Natural killer (NK) cells are key effectors of the innate immune system, protecting the host from a variety of infections, as well as malignant cells. Recent advances in the field of NK cell biology have led to a better understanding of how NK cells develop. This progress has directly translated to improved outcomes in patients receiving hematopoietic stem cell transplants to treat potentially lethal malignancies. However, key differences between mouse and human NK cell development and biology limits the use of rodents to attain a more in depth understanding of NK cell development. Therefore, a readily accessible and genetically tractable cell source to study human NK cell development is warranted. Our lab has pioneered the development of lymphocytes, specifically NK cells, from human embryonic stem cells (hESCs) and more recently induced pluripotent stem cells (iPSCs). This chapter describes a reliable method to generate NK cells from hESCs and iPSCs using murine stromal cell lines. Additionally, we include an updated approach using a spin-embryoid body (spin-EB) differentiation system that allows for human NK cell development completely defined in vitro conditions.Keywords
This publication has 11 references indexed in Scilit:
- Human Pluripotent Stem Cells Produce Natural Killer Cells That Mediate Anti-HIV-1 Activity by Utilizing Diverse Cellular MechanismsJournal of Virology, 2011
- Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activityBlood, 2009
- Efficient Hematopoietic Differentiation of Human Embryonic Stem Cells on Stromal Cells Derived from Hematopoietic NichesCell Stem Cell, 2008
- Genetic Modification of Human Embryonic Stem Cells for Derivation of Target CellsCell Stem Cell, 2008
- A protocol describing the use of a recombinant protein-based, animal product-free medium (APEL) for human embryonic stem cell differentiation as spin embryoid bodiesNature Protocols, 2008
- Directed Differentiation of Human Embryonic Stem Cells as Spin Embryoid Bodies and a Description of the Hematopoietic Blast Colony Forming AssayCurrent Protocols in Stem Cell Biology, 2008
- Efficient and Stable Transgene Expression in Human Embryonic Stem Cells Using Transposon-Mediated Gene TransferStem Cells, 2007
- Forced aggregation of defined numbers of human embryonic stem cells into embryoid bodies fosters robust, reproducible hematopoietic differentiationBlood, 2005
- Cytokine requirements differ for stroma and embryoid body-mediated hematopoiesis from human embryonic stem cellsExperimental Hematology, 2004
- Hematopoietic colony-forming cells derived from human embryonic stem cellsProceedings of the National Academy of Sciences, 2001